0000939798-17-000100.txt : 20171201 0000939798-17-000100.hdr.sgml : 20171201 20171201172539 ACCESSION NUMBER: 0000939798-17-000100 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170901 FILED AS OF DATE: 20171201 DATE AS OF CHANGE: 20171201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clarence-Smith Kathleen CENTRAL INDEX KEY: 0001721625 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-08092 FILM NUMBER: 171234986 MAIL ADDRESS: STREET 1: 1623 31ST STREET NW CITY: WASHINGTON STATE: DC ZIP: 20007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GT Biopharma, Inc. CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1825 K STREET STREET 2: SUITE 510 CITY: WASHINGTON, D.C. STATE: DC ZIP: 33602 BUSINESS PHONE: (800) 304-9888 MAIL ADDRESS: STREET 1: 1825 K STREET STREET 2: SUITE 510 CITY: WASHINGTON, D.C. STATE: DC ZIP: 33602 FORMER COMPANY: FORMER CONFORMED NAME: OXIS INTERNATIONAL INC DATE OF NAME CHANGE: 19940916 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 3 1 primary_doc.xml PRIMARY DOCUMENT X0206 3 2017-09-01 0 0000109657 GT Biopharma, Inc. GTBP 0001721625 Clarence-Smith Kathleen 1825 K STREET, SUITE 510 WASHINGTON DC 20006 1 1 1 0 CEO common stock 8505633 D /s/ Kathleen Clarence-Smith 2017-12-01